Table 5.
Influence of simulated gastrointestinal tract transit on Saccharomyces boulardii RC009 viability after technological procedures (lyophilisation or encapsulation + lyophilisation).
| Technological treatments | Log10 CFU during simulated gastrointestinal transit a |
||||
|---|---|---|---|---|---|
| II | SC | GC | IC | ||
| Lyophilisation | M b | 9.10 | 7.66 | 6.93 | 6.30 |
| WPC c | 9.10 | 7.56 | 7.25 | 6.90 | |
| Encapsulation + Lyophilisation | M | 6.75 | 5.60 | 5.02 | 4.78 |
| WPC | 6.93 | 5.70 | 4.95 | 4.40 | |
II: initial inoculum, SC: Salivary conditions tolerance assay, GC: Gastric conditions tolerance assay, IC: Intestinal conditions tolerance assay.
a
CFU: colony forming units.
b
M: Maltodextrin.
c
WPC: Whey protein concentrate.